teva glp 1 Pharmaceuticals Launches Liraglutide Injection 1.8 mg, First Generic GLP-1 in the US Teva wins FDA nod for

Xing et al., 2024)

Heise T, Mari A, DeVries JH et al (2022) Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial

References Ahmad, Y., Ullah, I., Rehman, M

Rice Powder & Microcrystalline Cellulose Stabilize the formula and maintain integrity

doi: 10.1016/j.molmet.2016.06.013 86 HarrisRBS

Sodium-glucose co-transporter 2 inhibitors (SGLT-2is) provide cardiorenal benefits, and reduction in weight, hemoglobin A1c (HbA1c), and systolic blood pressure, through various mechanisms involving nutrient-sensing pathways [2, 3]